The Journal of Urology
Volume 179, Issue 2 , Pages 622-623 , February 2008

Voiding Function and Dysfunction, Bladder Physiology and Pharmacology, and Female Urology

Reference 

    BXL-628, a Vitamin D Receptor Agonist Effective in Benign Prostatic Hyperplasia Treatment, Prevents RhoA Activation and Inhibits RhoA/Rho Kinase Signaling in Rat and Human Bladder
  1. Colli E, Rigatti P, Montorsi F, Artibani W, Petta S, Mondaini N, et al. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol. 2006;49:82
    Assessment of the Impact of Sildenafil Citrate on Lower Urinary Tract Symptoms in Men With Erectile Dysfunction
  1. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil influences lower urinary tract symptoms. BJU Int. 2002;90:836

PII: S0022-5347(07)02742-5

doi: 10.1016/j.juro.2007.10.019

The Journal of Urology
Volume 179, Issue 2 , Pages 622-623 , February 2008

Article Tools